ZA953418B - Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor - Google Patents
Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitorInfo
- Publication number
- ZA953418B ZA953418B ZA953418A ZA953418A ZA953418B ZA 953418 B ZA953418 B ZA 953418B ZA 953418 A ZA953418 A ZA 953418A ZA 953418 A ZA953418 A ZA 953418A ZA 953418 B ZA953418 B ZA 953418B
- Authority
- ZA
- South Africa
- Prior art keywords
- hmg
- amount
- acid derivative
- coa reductase
- reductase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4414537A DE4414537A1 (en) | 1994-04-26 | 1994-04-26 | Combination preparations containing a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA953418B true ZA953418B (en) | 1996-01-11 |
Family
ID=6516472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA953418A ZA953418B (en) | 1994-04-26 | 1995-04-26 | Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU2407895A (en) |
DE (1) | DE4414537A1 (en) |
EE (1) | EE9400258A (en) |
WO (1) | WO1995028924A1 (en) |
ZA (1) | ZA953418B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3326164A1 (en) * | 1983-07-20 | 1985-01-31 | Klinge Pharma GmbH, 8000 München | NEW P-OXIBENZOESAEE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
CA2003478A1 (en) * | 1988-12-12 | 1990-06-12 | Leonard G. Dennick | Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination |
CA2048395A1 (en) * | 1990-08-23 | 1992-02-24 | Henry Y. Pan | Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin |
DE4032037A1 (en) * | 1990-10-09 | 1992-04-16 | Klinge Co Chem Pharm Fab | NEW P-OXIBENZOESAE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS |
US5202029A (en) * | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
-
1994
- 1994-04-26 DE DE4414537A patent/DE4414537A1/en not_active Withdrawn
- 1994-11-11 EE EE9400258A patent/EE9400258A/en unknown
-
1995
- 1995-04-25 WO PCT/EP1995/001566 patent/WO1995028924A1/en active Application Filing
- 1995-04-25 AU AU24078/95A patent/AU2407895A/en not_active Abandoned
- 1995-04-26 ZA ZA953418A patent/ZA953418B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE4414537A1 (en) | 1995-11-02 |
AU2407895A (en) | 1995-11-16 |
WO1995028924A1 (en) | 1995-11-02 |
EE9400258A (en) | 1996-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1022795A (en) | Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor | |
HK1022105A1 (en) | Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor | |
HUP9900666A3 (en) | Phosphodiesterase inhibitor phenanthridines derivatives and use thereof | |
AU662997B2 (en) | Condensed heterocyclic derivative and weedkiller | |
AP9801401A0 (en) | Combination of an aldose reductase inhibitor and a glycogen phosphorlylase inhibitor | |
EP1009415A4 (en) | INHIBITORS OF $g(b)-LACTAMASES AND USES THEREFOR | |
AU2453295A (en) | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor | |
GB9200114D0 (en) | Dual inhibitors of no synthase and cyclooxygenase | |
AU4617696A (en) | Transformer and method of assembly | |
AU7204694A (en) | Fastening device for furniture construction and method of manufacture | |
AU6672598A (en) | Dual threaded fastener for metal components and method | |
AU1273297A (en) | Flame inhibitor composition and use thereof | |
AU2058992A (en) | HMG-COA reductase inhibitors | |
AU2907697A (en) | Decontamination of metal | |
AU2523897A (en) | A circulator and components thereof | |
GB2227662B (en) | Lowering serum cholesterol using a hmg coa reductase inhibitor and a squaline synthetase inhibitor | |
IL132786A0 (en) | Hmg-coa reductase inhibitor preparation process | |
IL114439A0 (en) | Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis | |
EP0461548A3 (en) | Method for preventing a second heart attack employing and hmg coa reductase inhibitor | |
ZA948337B (en) | Pyrrolidine derivatives inhibitors of leukotriene biosynthesis | |
ZA953418B (en) | Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor | |
AU3941389A (en) | Quinoline and pyridine anchors for a HMG-CoA reductase inhibitors | |
AU5659796A (en) | 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors | |
AU5014496A (en) | Diphenylmethyl-azetidinone compounds and elastase inhibitor | |
GB9303051D0 (en) | 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors |